Aberdeenshire, United Kingdom

Peter McCaffery

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: University of Durham. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peter McCaffery. Retrieved from https://idiyas.com/inventor/peter-mccaffery

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Peter McCaffery: Innovator in Synthetic Retinoids

Introduction

Peter McCaffery is a notable inventor based in Aberdeenshire, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of synthetic retinoids. His work focuses on the activation of retinoic acid receptors (RAR), which play a crucial role in various biological processes.

Latest Patents

Peter McCaffery holds a patent for "Synthetic retinoids for use in RAR activation." This invention relates to compounds designed to treat conditions alleviated by RAR activation. The patent outlines a method for screening compounds for therapeutic potential in treating such conditions. The compounds are defined by specific formulas, which include novel configurations that enhance their effectiveness.

Career Highlights

Peter McCaffery is affiliated with the University of Durham, where he continues to advance research in his field. His work has garnered attention for its potential applications in medicine, particularly in developing new treatments for diseases linked to retinoic acid receptors.

Collaborations

Peter has collaborated with esteemed colleagues, including Andrew Whiting and David Chisholm. These partnerships have contributed to the innovative research and development of new pharmaceutical compounds.

Conclusion

Peter McCaffery's contributions to synthetic retinoids and RAR activation highlight his role as a significant inventor in the pharmaceutical industry. His work promises to impact the treatment of various conditions, showcasing the importance of innovation in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…